Mail

UK markets closed

FTSE 100
8,139.83
+60.97(+0.75%)
FTSE 250
19,824.16
+222.18(+1.13%)
AIM
755.28
+2.16(+0.29%)
GBP/EUR
1.1679
+0.0022(+0.19%)
GBP/USD
1.2491
-0.0020(-0.16%)
Bitcoin GBP
51,127.23
-899.22(-1.73%)

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

Hansoh Pharmaceutical Group Company Limited (3692.HK)

HKSE - HKSE Delayed price. Currency in HKD

Add to watchlist

17.220

+0.420

(+2.50%)

At close: 04:08PM HKT

Currency in HKD

Valuation measures⁴

Market cap (intra-day)	99.63B
Enterprise value	77.40B
Trailing P/E	29.88
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	9.26
Price/book (mrq)	3.57
Enterprise value/revenue	7.66
Enterprise value/EBITDA	20.20

Trading information

Stock price history

Beta (5Y monthly)	0.56
52-week change ³	17.65%
S&P500 52-week change ³	21.08%
52-week high ³	17.260
52-week low ³	9.410
50-day moving average ³	14.785
200-day moving average ³	13.047

Share statistics

Avg vol (3-month) ³	5.6M
Avg vol (10-day) ³	4.63M
Shares outstanding ⁵	5.93B
Implied shares outstanding ⁶	5.93B
Float ⁸	1.07B
% held by insiders ¹	81.73%
% held by institutions ¹	9.36%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	0.21
Forward annual dividend yield ⁴	1.24%
Trailing annual dividend rate ³	0.19
Trailing annual dividend yield ³	1.15%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	21.36%
Dividend date ³	N/A
Ex-dividend date ⁴	19 Jun 2024
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	32.44%
Operating margin (ttm)	29.24%

Management effectiveness

Return on assets (ttm)	5.31%
Return on equity (ttm)	13.53%

Income statement

Revenue (ttm)	10.1B
Revenue per share (ttm)	1.71
Quarterly revenue growth (yoy)	13.00%
Gross profit (ttm)	N/A
EBITDA	3B
Net income avi to common (ttm)	3.28B
Diluted EPS (ttm)	0.560
Quarterly earnings growth (yoy)	54.70%

Balance sheet

Total cash (mrq)	24.86B
Total cash per share (mrq)	4.2
Total debt (mrq)	4.3B
Total debt/equity (mrq)	16.69%
Current ratio (mrq)	4.21
Book value per share (mrq)	4.35

Cash flow statement

Operating cash flow (ttm)	N/A
Levered free cash flow (ttm)	N/A